{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreia2hvraiydeke6ky6etilrnf3h6w75w42j2dqgnqvr7fy577bvncq",
    "uri": "at://did:plc:svcthvzunxmjidtlw23zva6n/app.bsky.feed.post/3miayzwspeed2"
  },
  "path": "/2026/03/30/qyuns-therapeutics-b-02509-2025-revenue-surges-over-4-fold-adjusted-profit-reaches-approximately-rmb356-million-turning-a-profit-year-on-year/",
  "publishedAt": "2026-03-30T04:39:00.000Z",
  "site": "https://laotiantimes.com",
  "tags": [
    "Cision PR Newswire"
  ],
  "textContent": "TAIZHOU, China, March 30, 2026 /PRNewswire/ — Qyuns Therapeutics-B (02509) announced its 2025 annual results. Revenue amounted to approximately RMB807 million, representing a 4.08-fold year-on-year increase. Gross profit reached approximately RMB714 million, a 6.75-fold increase year-on-year. Profit for the year was RMB307 million, while adjusted profit for the year reached approximately RMB356 million, turning a […]",
  "title": "Qyuns Therapeutics-B (02509) 2025 Revenue Surges Over 4-Fold; Adjusted Profit Reaches Approximately RMB356 Million, Turning a Profit Year-on-Year"
}